淋巴系统
细胞毒性T细胞
淋巴管内皮
癌症研究
淋巴管
转移
生物
淋巴结间质细胞
免疫疗法
免疫系统
T细胞
抗原
免疫学
癌症
体外
生物化学
遗传学
作者
Laure Garnier,Robert Pick,Julien Montorfani,Mengzhu Sun,Dale Brighouse,Nicolas Liaudet,Thomas Kammertoens,Thomas Blankenstein,Nicolas Pagé,Jeremiah Bernier‐Latmani,Ngoc Lan Tran,Tatiana V. Petrova,Doron Merkler,Christoph Scheiermann,Stéphanie Hugues
出处
期刊:Science Advances
[American Association for the Advancement of Science (AAAS)]
日期:2022-06-08
卷期号:8 (23)
被引量:28
标识
DOI:10.1126/sciadv.abl5162
摘要
Tumor-associated lymphatic vessels promote metastasis and regulate antitumor immune responses. Here, we assessed the impact of cytotoxic T cells on the local lymphatic vasculature and concomitant tumor dissemination during an antitumor response. Interferon-γ (IFN-γ) released by effector T cells enhanced the expression of immunosuppressive markers by tumor-associated lymphatic endothelial cells (LECs). However, at higher effector T cell densities within the tumor, T cell–based immunotherapies induced LEC apoptosis and decreased tumor lymphatic vessel density. As a consequence, lymphatic flow was impaired, and lymph node metastasis was reduced. Mechanistically, T cell–mediated tumor cell death induced the release of tumor antigens and cross-presentation by tumor LECs, resulting in antigen-specific LEC killing by T cells. When LECs lacked the IFN-γ receptor expression, LEC killing was abrogated, indicating that IFN-γ is indispensable for reducing tumor-associated lymphatic vessel density and drainage. This study provides insight into how cytotoxic T cells modulate tumor lymphatic vessels and may help to improve immunotherapeutic protocols.
科研通智能强力驱动
Strongly Powered by AbleSci AI